UK ki MHRA ne healthcare mein AI tools ke liye 'L-plate' approval framework launch kiya hai. Isse AI models bina kisi lambi delay ke clinical settings mein test ho sakenge, jisse innovation tezz hogi.
Kya hai ye 'L-plate' system?
UK ki MHRA ne healthcare mein AI ke integration ke liye ek naya roadmap taiyar kiya hai. Iska concept driving learner permit jaisa hai—'L-plate'. Matlab, koi bhi naya AI diagnostic tool direct final approval ka wait nahi karega, balki strict supervision aur real-time monitoring ke under clinics mein live test kiya ja sakega. Ye step 12,000 stakeholders se baat karne ke baad liya gaya hai.
Indian IT companies ke liye kya big deal hai?
Indian investors ko is par nazar rakhni chahiye kyunki TCS, Infosys, aur Wipro jaise giants NHS (National Health Service) ke saath bade digital projects par kaam karte hain. Agar UK mein regulatory process fast hota hai, toh in companies ke liye project lifecycles chote ho sakte hain aur business tezzi se grow kar sakta hai.
Risk bhi hain ya bas faayda?
Sab kuch itna smooth nahi hai. Is model mein continuous monitoring aur data transparency ki bahut zarurat hogi. Compliance aur auditing costs badh sakti hain. Agar koi AI tool real-world testing mein fail hota hai, toh use turant suspend kiya ja sakta hai, jo investment ke liye risky ho sakta hai.
UK ab EU AI Act ke muqable khud ko zyada flexible hub ke taur par dikha raha hai. Dekhte hain ki ye nayi strategy global health-tech players ko kitna attract karti hai.